Response to: ‘Is there a direct relationship between serum level of methotrexate and clinical efficacy and tolerability?’ by Fleishman and Yazici

Article info

Electronic pages

Correspondence response

Michael H Schiff Department of Rheumatology, University of Colorado, Englewood, Colorado, USA PubMed articles Google scholar articles
Jonathan S Jaffe Clinical Development, Antares Pharma Inc, Ewing, New Jersey, USA PubMed articles Google scholar articles
Bruce Freundlich Medical Department, Antares Pharma Inc, Ewing, New Jersey, USA PubMed articles Google scholar articles

Correspondence to Dr Michael H Schiff, Department of Rheumatology, University of Colorado, 5400 South Monaco, Englewood, Colorado CO 80111, USA; michael.schiff{at}me.com

Citation

Schiff MH, Jaffe JS, Freundlich B

Response to: ‘Is there a direct relationship between serum level of methotrexate and clinical efficacy and tolerability?’ by Fleishman and Yazici

Annals of the Rheumatic Diseases 2014;73:e55.

Online issue publication

October 25, 2017

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions